BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38646542)

  • 1. Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials.
    Zhang W; Liang Z; Zhao Y; Li Y; Chen T; Li W; Chen Y; Wu P; Zhang H; Fang C; Li L
    Front Immunol; 2024; 15():1359302. PubMed ID: 38646542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of tumour vaccine immunotherapy for the treatment of advanced non-small cell lung cancer: a systematic meta-analysis.
    Wang M; Cao JX; Liu YS; Xu BL; Li D; Zhang XY; Li JL; Liu JL; Wang HB; Wang ZX
    BMJ Open; 2015 Apr; 5(4):e006321. PubMed ID: 25872936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated management of stage III in nonsmall cell lung cancer: where do perioperative chemotherapy and immunotherapy fit?
    Collazo-Lorduy A; Blanco M; Calvo V; Provencio M
    Curr Opin Pulm Med; 2024 Jul; 30(4):346-351. PubMed ID: 38712693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of neoadjuvant chemotherapy combined with surgery in patients with nonsmall cell lung cancer: A meta-analysis.
    Dong HJ; Yang CY
    Clin Respir J; 2024 May; 18(5):e13756. PubMed ID: 38725310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative chemotherapy versus adjuvant chemotherapy in patients with resectable gastric cancer: A systematic review with meta-analysis.
    Wei C; Du X; Hu J; Dong Y; Chen Y; Cao B
    Crit Rev Oncol Hematol; 2024 Jun; 198():104082. PubMed ID: 37532103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of immune checkpoint inhibitor combined with other targeted or immunological therapy regimens for the treatment of advanced bile tract cancer: a systematic review and meta-analysis.
    Zhou J; Li J; Fan Z; Lv G; Wang G
    Front Immunol; 2024; 15():1378760. PubMed ID: 38840927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological response in resectable non-small cell lung cancer: a systematic literature review and meta-analysis.
    Waser NA; Quintana M; Schweikert B; Chaft JE; Berry L; Adam A; Vo L; Penrod JR; Fiore J; Berry DA; Goring S
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38521542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving Immunotherapy Into the Treatment of Resectable Non-Small Cell Lung Cancer.
    Chaft JE; Dziadziuszko R; Haddock Lobo Goulart B
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432500. PubMed ID: 38788177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer patients: a systematic review.
    Yang L; Cui X; Wu F; Chi Z; Xiao L; Wang X; Liang Z; Li X; Yu Q; Lin X; Gao C
    Front Immunol; 2024; 15():1392499. PubMed ID: 38846948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease.
    Sathiyapalan A; Baloush Z; Ellis PM
    Curr Oncol; 2023 Oct; 30(11):9514-9529. PubMed ID: 37999109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of different cycles of neoadjuvant immunotherapy in resectable non-small cell lung cancer: A systematic review and meta-analysis.
    Ye L; Liu Y; Xiang X; Wang Z; Peng W; Wei X; Zhang S; Xue Q; Zhou Q
    Heliyon; 2024 Jun; 10(11):e31549. PubMed ID: 38828349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant immunotherapy improves outcomes for resectable gastroesophageal junction cancer: A systematic review and meta-analysis.
    Wu D; Yang L; Yan Y; Jiang Z; Liu Y; Dong P; Lv Y; Zhou S; Qiu Y; Yu X
    Cancer Med; 2024 May; 13(9):e7176. PubMed ID: 38716645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer.
    Feldman H; Sepesi B; Leung CH; Lin H; Weissferdt A; Pataer A; William WN; Walsh GL; Rice DC; Roth JA; Mehran RJ; Hofstetter WL; Antonoff MB; Rajaram R; Gibbons DL; Lee JJ; Heymach JV; Vaporciyan AA; Swisher SG; Cascone T
    J Thorac Cardiovasc Surg; 2024 Apr; 167(4):1444-1453.e4. PubMed ID: 37816395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative Immunotherapy in Non-Small Cell Lung Cancer.
    O'Brien J; Bodor JN
    Curr Treat Options Oncol; 2023 Dec; 24(12):1790-1801. PubMed ID: 38091187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive immunotherapy with interleukin-2 & induced killer cells in non-small cell lung cancer: A systematic review & meta-analysis.
    Mi D; Ren W; Yang K
    Indian J Med Res; 2016 May; 143(Supplement):S1-S10. PubMed ID: 27748271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine adverse events in patients with cancer receiving perioperative immune checkpoint blockade: a meta-analysis of randomized controlled trials.
    Zhou S; Horita N; Shao T; Harrington M; Fujiwara Y
    Ther Adv Med Oncol; 2024; 16():17588359241257874. PubMed ID: 38845790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of postoperative bronchopleural fistula after neoadjuvant immunochemotherapy in non-small cell lung cancer: case reports and review of the literature.
    Zhao R; Guan X; Zhang P; Liu Y; Xu Y; Sun C; Qiu S; Zhu W; Yang Z; Wang X
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):175. PubMed ID: 38573518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study.
    Tsuboi M; Murakami H; Harada H; Sobue T; Kato T; Atagi S; Tokito T; Mio T; Adachi H; Kozuki T; Sone T; Seike M; Toyooka S; Kitagawa H; Koto R; Yamazaki S; Horinouchi H
    Thorac Cancer; 2024 May; ():. PubMed ID: 38812106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of metformin on melanoma: a meta-analysis and systematic review.
    Feng H; Shang S; Chen K; Sun X; Yue X
    Front Oncol; 2024; 14():1399693. PubMed ID: 38846983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nutrition-related adverse events associated with immune checkpoint inhibitor treatment for patients with non-small cell lung cancer: A systematic review.
    Graham KL; Carty D; Poulter SP; Blackman C; Dunstan OG; Milton TL; Ferguson C; Smith K; Van Dijk E; Jongebloed D; Loeliger J; Baguley BJ
    Nutr Diet; 2024 May; ():. PubMed ID: 38804022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.